Isabelle Ray‐Coquard

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)

Stefan Sleijfer, Isabelle Ray‐Coquard, Zsuzsa Pápai et al. · Journal of Clinical Oncology · 2009 · 681 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study

Isabelle Ray‐Coquard, Jean‐Yves Blay, Antoîne Italiano et al. · The Lancet Oncology · 2012 · 563 citations

Medicine, Cancer Biology, Oncology +16

Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing

Françoise Ducimetière, A. Lurkin, Dominique Ranchère‐Vince et al. · PLoS ONE · 2011 · 546 citations · Full text

Medicine, Oncology, Pathology +17

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

Axel Le Cesne, Jean‐Yves Blay, Ian Judson et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Oncology, Pharmacology +16

Improved survival using specialized multidisciplinary board in sarcoma patients

Jean‐Yves Blay, Pauline Soibinet, Nicolas Penel et al. · Annals of Oncology · 2017 · 362 citations · Full text

Medicine, Oncology, Surgery +10